[Federal Register: August 3, 2006 (Volume 71, Number 149)]
[Notices]
[Page 44035]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03au06-58]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
National Mammography Quality Assurance Advisory Committee; Notice
of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: National Mammography Quality Assurance Advisory
Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on September 28, 2006, from
10 a.m. to 6 p.m., and on September 29, 2006, from 8 a.m. to 1 p.m.
Location: Atrium Court Hotel, Remington 1 and 2, Three Research
Ct., Rockville, MD.
Contact Person: Nancy Wynne, Center for Devices and Radiological
Health (HFZ-240), Food and Drug Administration, 1350 Piccard Dr.,
Rockville, MD 20850, 240-276-3284, or FDA Advisory Committee
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC
area), code 3014512397. Please call the Information Line for up-to-date
information on this meeting.
Agenda: The committee will discuss: (1) Amendments to the current
regulations, and (2) all guidance documents issued since the last
meeting. The committee will also receive updates on recently approved
alternative standards and the radiological health program. MQSA
regulations and guidance documents are available to the public on the
Internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/cdrh/mammography.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
August 29, 2006. Oral presentations from the public will be scheduled
between approximately 10:30 a.m. and 11:30 a.m. on September 28, 2006,
and between approximately 8:30 a.m. and 9:30 a.m. on September 29,
2006. Time allotted for each presentation may be limited. Those
desiring to make formal oral presentations should notify the contact
person and submit a brief statement of the general nature of the
evidence or arguments they wish to present, the names and addresses of
proposed participants, and an indication of the approximate time
requested to make their presentation on or before August 29, 2006.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Shirley Meeks,
Conference Management Staff, at 301-827-7292, at least 7 days in
advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: July 27, 2006.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E6-12569 Filed 8-2-06; 8:45 am]
BILLING CODE 4160-01-S